Klingenstein Fields & CO LP Abbott Laboratories Transaction History

Klingenstein Fields & CO LP

$2.49 Billion
Q2 2025

A detailed history of Klingenstein Fields & CO LP transactions in Abbott Laboratories stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 115,720 shares of ABT stock, worth $15.6 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

115,720

Previous 130,257 11.16%

Holding current value

$15.6 Million

Previous $17.3 Million 8.91%

% of portfolio

0.63%

Previous 0.74%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$123.95 - $138.08 $1.8 Million - $2.01 Million	-14,537 Reduced 11.16%	115,720 $15.7 Million
Q1 2025 Apr 28, 2025	BUY	$111.1 - $140.22 $17,220 - $21,734	155 Added 0.12%	130,257 $17.3 Million
Q4 2024 Jan 30, 2025	BUY	$111.93 - $119.39 $302,322 - $322,472	2,701 Added 2.12%	130,102 $14.7 Million
Q3 2024 Oct 29, 2024	BUY	$100.07 - $118.13 $17,111 - $20,200	171 Added 0.13%	127,401 $14.5 Million
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $13,497 - $15,066	134 Added 0.11%	127,230 $13.2 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $236,453 - $261,152	-2,159 Reduced 1.67%	127,096 $14.4 Million
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $217,808 - $266,616	-2,415 Reduced 1.83%	129,255 $14.2 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $15,475 - $18,568	-162 Reduced 0.12%	131,670 $12.8 Million
Q2 2023 Aug 01, 2023	SELL	$100.78 - $112.29 $209,622 - $233,563	-2,080 Reduced 1.55%	131,832 $14.4 Million
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $131,439 - $154,711	1,357 Added 1.02%	133,912 $13.6 Million
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $14,829 - $17,397	156 Added 0.12%	132,555 $14.6 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $164,782 - $190,787	1,703 Added 1.3%	132,399 $12.8 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $107,479 - $129,908	-1,053 Reduced 0.8%	130,696 $14.2 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $38,538 - $46,995	338 Added 0.26%	131,749 $15.6 Million
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $183,692 - $224,921	-1,590 Reduced 1.2%	131,411 $18.5 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $346,596 - $383,437	-2,971 Reduced 2.19%	133,001 $15.7 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $421,255 - $495,878	-3,982 Reduced 2.85%	135,972 $15.8 Million
Q1 2021 Apr 29, 2021	BUY	$108.84 - $128.23 $28,080 - $33,083	258 Added 0.18%	139,954 $16.8 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $160,860 - $175,291	1,532 Added 1.11%	139,696 $15.3 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $103,644 - $125,868	-1,131 Reduced 0.81%	138,164 $15 Million
Q2 2020 Aug 03, 2020	BUY	$76.57 - $98.0 $749,850 - $959,714	9,793 Added 7.56%	139,295 $12.7 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $44,602 - $65,220	710 Added 0.55%	129,502 $10.2 Million
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $84,712 - $94,304	-1,079 Reduced 0.83%	128,792 $11.2 Million
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $210,656 - $228,416	-2,574 Reduced 1.94%	129,871 $10.9 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $505,787 - $589,900	6,940 Added 5.53%	132,445 $11.1 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $1.87 Million - $2.26 Million	28,221 Added 29.01%	125,505 $10 Million
Q4 2018 Jan 22, 2019	BUY	$65.56 - $74.27 $510,056 - $577,820	7,780 Added 8.69%	97,284 $7.04 Million
Q3 2018 Nov 01, 2018	BUY	$60.81 - $73.36 $3.35 Million - $4.05 Million	55,148 Added 160.52%	89,504 $6.57 Million
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $46,701 - $49,998	-870 Reduced 2.47%	34,356 $1.96 Million
Q3 2017 Nov 01, 2017	BUY	$48.06 - $53.64 $1.69 Million - $1.89 Million	35,226	35,226 $1.88 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Account

Klingenstein Fields & CO LP Abbott Laboratories Transaction History